Creating a successful and sustainable business is about more than financial results.
We place great importance not just on what we achieve but on how we achieve it. We report on our approach and performance on responsible business issues in our 2010 Corporate Responsibility Review and Report. This is part of our commitment to be open and transparent about our business activities.
Funding external partners
We interact with external groups throughout the research, development and marketing of our medicines and vaccines, and aim to be transparent about these.
Values
Deirdre Connelly (President, North American Pharmaceuticals) outlines actions to transform GSK US sales & marketing practices
Commitment
Our CEO Sir Andrew Witty shares his views on innovation in global health in the January 2011 edition of leading US journal Health Affairs.